Skip to main content

Ingenuity, GeneInsight to Collaborate on Interpretation Software for Clinical Laboratories

Premium

Ingenuity Systems said this week that it is partnering with GeneInsight, a wholly owned subsidiary of Partners HealthCare, to develop an integrated workflow solution that will include tools for annotating, analyzing, assessing, and reporting human variants from next-generation sequencing-based tests.

Heidi Rehm, chief laboratory director of Partners' laboratory for molecular medicine, said in a statement that "the combined solution will incorporate knowledge about genomic variation from the Ingenuity offering with GeneInsight's knowledge management and reporting infrastructure, helping to streamline the overall workflow for very broad spectrum tests.”

Under the terms of the agreement, Ingenuity will provide content and software for the analysis and biological interpretation of variants from sequencing-based tests. GeneInsight will provide genetic testing laboratories and providers with networked infrastructure to support interpretation, reporting, and management of genetic data.

Additional details were not disclosed.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.